# Rivastigmine 24HR Patches

Notice bc4f05cccd8541ebadc3df750a514114 (solicitation SPE2D221R0113) from DEPT OF DEFENSE, DLA TROOP SUPPORT, posted 2023-08-22, responses due -. Status: open.

| Field | Value |
| --- | --- |
| Notice ID | bc4f05cccd8541ebadc3df750a514114 |
| Solicitation number | SPE2D221R0113 |
| Type | Award Notice |
| Agency | DEPT OF DEFENSE |
| Sub-tier | DEFENSE LOGISTICS AGENCY |
| Office | DLA TROOP SUPPORT |
| Posted | 2023-08-22T19:27:16.000Z |
| Response deadline (UTC) | - |
| Set-aside | - |
| NAICS | 325412 |
| PSC | 6505 |
| Place of performance | Saint Albans, VT, USA |
| Award | SPE2D222D0147 to Mylan Pharmaceuticals Inc. Morgantown WV 26505 USA, $10,967,220 |

## Description

Modification SPE2D222D0147 P00003 to Invoke Option Year 1 for the period of September 14, 2023 through September 13, 2024. Modification SPE2D222D0147 P00002 to incoporate Drug Supply Chain Security Act (DCSA) into solicitation for subject contract. Modification SPE2D222D0147 P00001 to incorporate clause FAR 52.204-27 Prohibituion on a Bytedance covered JApplication (June 2023) into subject contract. Contract Award for Rivastigmine 24HR Patches SPE2D222D0147.

## Sources

- View on SAM.gov: https://sam.gov/opp/bc4f05cccd8541ebadc3df750a514114/view
- Data as of 2026-11-14. Source: https://sam.gov/data-services/Contract%20Opportunities/datagov

## Cite this

"Rivastigmine 24HR Patches, SAM.gov contract opportunity bc4f05cccd8541ebadc3df750a514114." samgovapi.io, https://samgovapi.io/opportunity/bc4f05cccd8541ebadc3df750a514114, data as of 2026-11-14. Primary record: https://sam.gov/opp/bc4f05cccd8541ebadc3df750a514114/view

## API and MCP

- REST: GET https://samgovapi.io/api/v1/opportunities/bc4f05cccd8541ebadc3df750a514114
- MCP tool: get_opportunity

Independent. Not affiliated with, endorsed by or sponsored by GSA, SAM.gov or any U.S. government agency. Registering in SAM.gov is free at sam.gov.

Get a free API key: https://samgovapi.io/sign-up?ref=ai-claudebot